Drug Discovery Research, Astellas Pharma Inc.
Chem Pharm Bull (Tokyo). 2021;69(4):360-373. doi: 10.1248/cpb.c20-00877.
The M muscarinic acetylcholine receptor (mAChR) plays an essential pharmacological role in mediating a broad range of actions of acetylcholine (ACh) released throughout the periphery and central nerve system (CNS). Nevertheless, its agonistic functions remain unclear due to the lack of available subtype-selective agonists or positive allosteric modulators (PAMs). In the course of our extended structure-activity relationships (SARs) study on 2-acylaminothiazole derivative 1, a previously reported PAM of the M mAChR, we successfully identified N-pyrimidyl/pyridyl-2-thiazolamine analogues as new scaffolds. The SARs study was rationalized using conformational analyses based on intramolecular interactions. A comprehensive study of a series of analogues described in this paper suggests that a unique sulfur-nitrogen nonbonding interaction in the N-pyrimidyl/pyridyl-2-thiazolamine moiety enable conformations that are essential for activity. Further, a SARs study around the N-pyrimidyl/pyridyl-2-thiazolamine core culminated in the discovery of compound 3g, which showed potent in vitro PAM activity for the M mAChR with excellent subtype selectivity. Compound 3g also showed a distinct pharmacological effect on isolated smooth muscle tissue from rat bladder and favorable pharmacokinetics profiles, suggesting its potential as a chemical tool for probing the M mAChR in further research.
M 毒蕈碱型乙酰胆碱受体 (mAChR) 在介导乙酰胆碱 (ACh) 在周围和中枢神经系统 (CNS) 释放的广泛作用中发挥着重要的药理学作用。然而,由于缺乏可用的亚型选择性激动剂或正变构调节剂 (PAMs),其激动作用仍不清楚。在我们对 2-酰氨基噻唑衍生物 1 的扩展构效关系 (SAR) 研究过程中,我们成功地鉴定出 N-嘧啶基/吡啶基-2-噻唑胺类似物作为新的支架。SAR 研究是基于分子内相互作用的构象分析合理化的。本文中描述的一系列类似物的综合研究表明,N-嘧啶基/吡啶基-2-噻唑胺部分中独特的硫-氮非键相互作用使构象成为必需的活性。此外,围绕 N-嘧啶基/吡啶基-2-噻唑胺核心的 SAR 研究最终发现了化合物 3g,它对 M mAChR 表现出很强的体外 PAM 活性,具有优异的亚型选择性。化合物 3g 还对大鼠膀胱分离平滑肌组织表现出明显的药理学作用和良好的药代动力学特征,这表明它有潜力成为进一步研究 M mAChR 的化学工具。